Trials / Not Yet Recruiting
Not Yet RecruitingNCT07125950
SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer
A Phase 2 Trial of SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Henan Cancer Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Our study is aimed to evaluate the safety and preliminary of all-oral regimen SHR2554 combined with HRS-8080 or HRS-1358 in advanced breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR2554 | SHR2554 |
| DRUG | HRS-8080 | HRS-8080 |
| DRUG | HRS-1358 | HRS-1358 |
Timeline
- Start date
- 2025-09-30
- Primary completion
- 2027-09-30
- Completion
- 2028-01-31
- First posted
- 2025-08-15
- Last updated
- 2025-08-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07125950. Inclusion in this directory is not an endorsement.